Table 4.
exercise time (min.) | treatment |
F-value | ||
---|---|---|---|---|
placebo | training | thiamine | ||
5 | 10.74±0.43 | 9.33±2.00 | 9.11±1.96a | |
10 | 11.67±1.12 | 10.22±2.11a | 10.11±2.03a | |
15 | 12.44±0.88 | 11.00±2.40a | 11.00±2.06a | |
20 | 12.78±1.20 | 11.11±2.20a | 11.11±2.09a | |
25 | 13.22±1.20 | ll.ll±1.96a | 11.33±1.80a | treat 18.160* |
30 | 13.56±1.42 | 11.56±1.94a | 11.67±1.73a | time 22.148* |
35 | 13.56±1.24 | 11.78±2.11a | 12.00±1.50a | |
40 | 13.67±1.58 | 12.00±1.32a | 12.33±1.94a | treat×time 1.000 |
45 | 14.56±2.13 | 12.44±1.51a | 12.44±2.01a | |
50 | 14.67±1.94 | 12.48±1.23a | 12.67±1.80a | |
55 | 15.45±1.33 | 13.11±2.42a | 12.67±2.00a | |
60 | 15.11±2.57 | 13.56±2.51a | 12.56±1.94a |
: indicates significant interaction or main effect(p < .05)
: indicates difference from treatment of placebo(p < .05)
: indicates difference from treatment of thiamine(p < .05)
treat : treatment